Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
931 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Not yet recruiting Locally Advanced NSCLC Hyperfractionated RT
Condition: Carcinoma, Non Small Cell Lung (NSCLC)
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Daily hyperfractionated radiation therapy
22 Not yet recruiting AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Condition: Advanced NSCLC
Intervention: Drug: Alflutinib
23 Recruiting Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung;   Drug-Related Side Effects and Adverse Reactions
Intervention: Other: Consultation of the patient's medical files at the hospital
24 Recruiting Study of ADCT-502 in Patients With Advanced Solid Tumors With HER2 Expression
Conditions: Breast Cancer;   Non Small Cell Lung Cancer;   GastroEsophageal Cancer;   Bladder Cancer
Intervention: Drug: ADCT-502
25 Recruiting Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Procedure: sublobar resection;   Procedure: lobectomy
26 Not yet recruiting Understanding Evidence-Based Practice Patterns in Advanced NSCLC
Condition: Non Small Cell Lung Cancer
Intervention: Behavioral: Carevive CPS
27 Not yet recruiting Atezolizumab Immunotherapy in Patients With Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Atezolizumab
28 Recruiting Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer
Condition: Leptomeningeal Metastases
Interventions: Drug: Pemetrexed;   Drug: Dexamethasone
29 Not yet recruiting Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Vinblastine Sulfate;   Radiation: three dimensional conformal radiotherapy
30 Recruiting A Study of AK-01 in Solid Tumors
Conditions: Solid Tumor;   Neoplasms;   Neoplasm Metastasis;   Small Cell Lung Cancer;   Breast Cancer
Intervention: Drug: AK-01
31 Recruiting A Study of Epacadostat in Combination With a PD-1 Inhibitor and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207)
Conditions: Advanced or Metastatic Solid Tumors;   Advanced or Metastatic Colorectal Cancer (CRC);   Pancreatic Ductal Adenocarcinoma (PDAC);   Non-Small Cell Lung Cancer (NSCLC; Squamous or Nonsquamous);   Advanced or Metastatic Solid Tumor That Progressed on Previous Therapy With a Programmed Cell Death Protein 1 (PD-1) Inhibitor;   Advanced or Metastatic Solid Tumor That Progressed on Previous Therapy With a Programmed Cell Death Ligand 1 (PD-L1) Inhibitor
Interventions: Drug: Epacadostat;   Drug: Nivolumab;   Drug: Pembrolizumab;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: 5-Fluorouracil;   Drug: Gemcitabine;   Drug: nab-Paclitaxel;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pemetrexed;   Drug: Cyclophosphamide
32 Not yet recruiting A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: SHR-1210;   Drug: Apatinib
33 Not yet recruiting Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer:Multicenter Controlled Study.(RadimiR-01)
Condition: Advanced Nsclc
Intervention: Radiation: radiotherapy
34 Not yet recruiting PDR001 in Combination With Platinum-doublet Chemotherapy in PD-L1 Unselected, Metastatic NSCLC Patients (ElevatION:NSCLC-101 Trial)
Condition: Non-small Cell Lung Cancer
Interventions: Drug: PDR001;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Paclitaxel
35 Recruiting A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies
Condition: Non-Small Cell Lung Cancer
Intervention: Device: Video-Assisted Thoracoscopic Lobectomy with powered vascular stapler
36 Not yet recruiting Multicentric Retrospective Prognostic Evaluation of Tumor Volume and Their Changes in Radical Radiotherapy of Locally Advanced NSCLC
Condition: Non Small Cell Lung Cancer Stage III
Intervention: Radiation: Radiation
37 Recruiting Preliminary Evaluation of Safety and Efficacy of Patients Who Participant in [14C] AC0010 Trail and Subsequent Receiving AC0010 Treatment
Condition: Carcinoma,Non-Small-Cell Lung
Intervention: Drug: AC0010
38 Recruiting A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Lorlatinib;   Drug: Crizotinib
39 Recruiting A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin;   Drug: Pemetrexed
40 Recruiting Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR TKI Therapy
Conditions: Non-Small Cell Carcinoma of Lung, TNM Stage 4;   Non-Small Cell Lung Cancer;   EGFR Gene Mutation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.